Home
Novavax NVAX paid Crossroads Strategies $50K for lobbying in Q3 2024 · Health Issues
Trade details
- Type
- Lobbying report
- Amount
- $50,000
- Quarter
- Q3 2024
- Stock
- Novavax NVAX
- Client
- Novavax
- Reported
- 24/10/20
Up 0.0% from last quarter
What else happened in Novavax around then
Filed or reported within 30 days of the trade day · 24/08/31~24/10/30Novavax's other lobbying reports
- Novavax
LobbyingNovavax
LobbyingNovavax
NVAX
$130K
$130K
Reported 07/17
for Q2
- Novavax
LobbyingNovavax
LobbyingNovavax
NVAX
$50K
$50K
Reported 07/16
for Q2
- Novavax
LobbyingNovavax
LobbyingNovavax
NVAX
$50K
$50K
Reported 07/15
for Q2
- Novavax
LobbyingNovavax
LobbyingNovavax
NVAX
$140K
$140K
Reported 04/20
for Q1
- Novavax
LobbyingNovavax
LobbyingNovavax
NVAX
$50K
$50K
Reported 04/16
for Q1